耐多药肺结核治疗管理模式现状  

The Status about the Mode of Treatment and Management of Multidrug-resistant Tuberculosis

作　　者：马慧芬[1,2] 孔鹏[1] 孟庆跃[1] 

机构地区：[1]山东大学卫生管理与政策研究中心,山东济南250012 [2]山东医学高等专科学校,山东济南250001

出　　处：《医学与哲学（B）》2012年第6期74-76,共3页Medicine & Philosophy(B)

基　　金：科技部重大专项肺结核发病模式研究;项目编号:2008ZX10003-007

摘　　要：耐多药肺结核发病率呈逐年上升趋势,世界各国采取了一系列治疗管理模式进行控制,文章对现存的几种治疗管理模式进行了描述分析。目的是为我国在"全国结核病防治规划"层面上建立起适宜的耐多药肺结核防治技术策略和防治管理模式提供科学依据。The incidence of Multidrug--resistant tuberculosis increased year by year, many countries in the world have adopted a series of managing and treating modes to control. It is very important to establish the mode of treatment and man- agement of Muttidrug--resistant tuberculosis. Now the existing modes can be classified as three categories： the centralized mode, the decentralized mode and a combination of the two. In our country, the treatment and management of all patients with tuberculosis, there is no difference for multi--drug resistant tuberculosis patients. This article describes the existing modes of treatment and management. So that it can provide scientific basis for establishing the appropriate level of Multidrug--resistant tuberculosis control strategies and control management technology in our country ＂National Tuberculosis Control Program＂.

关 键 词：耐多药肺结核 模式 现状 

分 类 号：R521[医药卫生—内科学]